List view / Grid view

Bristol-Myers Squibb



Bristol-Myers Squibb and Lonza expand biologics manufacturing agreement

31 October 2014 | By

Bristol-Myers Squibb Company and Lonza today announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, New Hampshire. Financial terms were not disclosed.